Hybrid liposomal PEGylated calix[4]arene systems as drug delivery platforms for curcumin

International Journal of Pharmaceutics

Volumn 472, Issue 1-2, 2014, Pages 165-174

  Drakalska, Elena ^a   Momekova, Denitsa ^a   Manolova, Yana ^b   Budurova, Dessislava ^c   Momekov, Georgi ^a   Genova, Margarita ^d   Antonov, Liudmil ^b   Lambov, Nikolay ^a   Rangelov, Stanislav ^c  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b INSTITUTE OF ORGANIC CHEMISTRY   (Bulgaria)

^c INSTITUTE OF POLYMERS   (Bulgaria)

^d National Specialized Hospital for Active Treatment of Hematological Diseases   (Bulgaria)

Author keywords

Calix 4 arenes; Curcumin; Cytotoxicity; Hybrid liposomal system; Inclusion complexes; Liposomes

Indexed keywords

CURCUMIN; DIPALMITOYLPHOSPHATIDYLCHOLINE; DRUG CARRIER; POLYOXYETHYLENE DERIVATIVE; TERT BUTYLCALIX[4]ARENE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CALIX(4)ARENE; CALIXARENE; CHOLESTEROL; LIPOSOME; MACROGOL DERIVATIVE; PHENOL DERIVATIVE;

ARTICLE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; DRUG STORAGE; ENCAPSULATION; EVAPORATION; FEASIBILITY STUDY; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; HEATING; HUMAN; HUMAN CELL; IC 50; MICELLIZATION; PRIORITY JOURNAL; SOLUBILIZATION; THERMOGRAVIMETRY; ULTRAVIOLET SPECTROSCOPY; ZETA POTENTIAL; APOPTOSIS; CELL CYCLE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; SOLUBILITY; TUMOR CELL LINE;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CALIXARENES; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CHOLESTEROL; CURCUMIN; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; PHENOLS; POLYETHYLENE GLYCOLS; SOLUBILITY;

EID: 84903128596     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.06.034     Document Type: Article

References (65)

1. B.B. Aggarwal Nuclear factor-κB: the enemy within Cancer Cell 6 2004 203 208
2. P. Arya, and K. Pathak Assessing the viability of microsponges as gastro retentive drug delivery system of curcumin: optimization and pharmacokinetics Int. J. Pharm. 460 2014 1 12
3. C. Avendaño, and J.C. Menéndez Medicinal Chemistry of Anticancer Drugs 2008 Elsevier Amsterdam
4. J. Barry, M. Fritz, J.R. Brender, P.E.S. Smith, D.K. Lee, and A. Ramamoorthy Determining the effects of lipophilic drugs on membrane structure by solid-state NMR spectroscopy: the case of the antioxidant curcumin J. Am. Chem. Soc. 131 2009 4490 4498
5. S. Barui, S. Saha, G. Mondal, S. Haseena, and A. Chaudhuri Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature Biomaterials 35 2014 1643 1656
6. K. Berginc, S. Suljakovic, N. Skalko-Basnet, and A. Kristl Mucoadhesive liposomes as new formulation for vaginal delivery of curcumin Eur. J. Pharm. Biopharm. 2014 10.1016/j.ejpb.2014.02.006 S0939-6411(14)00051-4 [pii]
7. A. Casnati, D. Sciotto, and G. Arena Water soluble calixarenes Z. Asfari, V. Böhmer, J. Harrowfield, J. Vicens, Calixarenes 2001 Kluwer Dordrecht 440 456
8. A. Casnati, F. Sansone, and R. Ungaro Peptido- and glycocalixarenes: playing with hydrogen bonds around hydrophobic cavities Acc. Chem. Res. 36 2003 246 254
9. H. Chen, J. Wu, M. Sun, C. Guo, A. Yu, F. Cao, L. Zhao, Q. Tan, and G. Zhai N-trimethyl chitosan chloride-coated liposomes for the oral delivery of curcumin J. Liposome Res. 22 2012 100 109
10. P. Cornago, P. Cabildo, D. Sanz, R.M. Claramunt, M.C. Torralba, M.R. Torres, and J.J. Elguero Structures of hemi-curcuminoids in the solid state and in solution Eur. J. Org. Chem. 27 2013 6043 6054
11. E. Da Silva, A.N. Lazar, and A.W. Coleman Biopharmaceutical applications of calixarenes J. Drug Deliv. Sci. Tech. 14 2004 3 20 (Pubitemid 38443342)
12. P.R. Dandawate, A. Vyas, A. Ahmad, S. Banerjee, J. Deshpande, K.V. Swamy, A. Jamadar, A.C. Dumhe-Klaire, S. Padhye, and F.H. Sarkar Inclusion complex of novel curcumin analogue CDF and beta-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer Pharm. Res. 29 2012 1775 1786
13. S.S. Dhule, P. Penfornis, T. Frazier, R. Walker, J. Feldman, G. Tan, J. He, A. Alb, V. John, and R. Pochampally Curcumin-loaded gamma-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma Nanomedicine 8 2012 440 451
14. C.S. Divya, and M.R. Pillai Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis Mol. Carcinog. 45 2006 320 332
15. R. Feng, Z. Song, and G. Zhai Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles Int. J. Nanomed. 7 2012 4089 4098
16. E. Ferari, M. Asti, R. Benassi, F. Pignedoli, and M. Saladini Metal binding ability of curcumin derivatives: a theoretical vs. experimental approach Dalton Trans. 42 2013 5304 5313
17. D.A. Fulton, and J.F. Stoddart Neoglycoconjugates based on cyclodextrins and calixarenes Bioconjug. Chem. 12 2001 655 672 (Pubitemid 32925867)
18. Y. Gao, Z. Li, M. Sun, H. Li, C. Guo, J. Cui, A. Li, F. Cao, Y. Xi, H. Lou, and G. Zhai Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer Drug Dev. Ind. Pharm. 36 2010 1225 1234
19. K. Gardikis, K. Dimas, A. Georgopoulos, E. Kaditi, S. Pispas, and C. Demetzos β - lactam functionalized poly(isoprene-b-ethylene oxide) amphiphilic block copolymer micelles as a new nanocarrier system for curcumin Curr. Nanosci. 6 2010 277 284
20. V.S. Gota, G.B. Maru, T.G. Soni, T.R. Gandhi, N. Kochar, and M.G. Agarwal Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers J. Agric. Food Chem. 58 2010 2095 2099
21. M. Hadjidemetriou, N. Pippa, S. Pispas, and C. Demetzos Incorporation of dimethoxycurcumin into charged liposomes and the formation kinetics of fractal aggregates of uncharged vectors J. Liposome Res. 23 2013 94 100
22. T. Harada, D.T. Pham, M.H. Leung, H.T. Ngo, S.F. Lincoln, C.J. Easton, and T.W. Kee Cooperative binding and stabilization of the medicinal pigment curcumin by diamide linked gamma-cyclodextrin dimers: a spectroscopic characterization J. Phys. Chem. B 115 2011 1268 1274
23. T. Harada, L. Giorgio, T.J. Harris, D.T. Pham, H.T. Ngo, E.F. Need, B.J. Coventry, S.F. Lincoln, C.J. Easton, G. Buchanan, and T.W. Kee Diamide linked gamma-cyclodextrin dimers as molecular-scale delivery systems for the medicinal pigment curcumin to prostate cancer cells Mol. Pharm. 10 2013 4481 4490
24. A.B. Hegge, R.B. Schuller, S. Kristensen, and H.H. Tonnesen In vitro release of curcumin from vehicles containing alginate and cyclodextrin. Studies of curcumin and curcuminoides. XXXIII Pharmazie 63 2008 585 592
25. T. Higuchi, and K.A. Connors Phase-solubility techniques Adv. Anal. Chem. Instrum. 1965 117 212
26. W.C. Hung, F.Y. Chen, C.C. Lee, Y. Sun, M.T. Lee, and H.W. Huang Membrane-thinning effect of curcumin Biophys. J. 94 2008 4331 4338
27. Y. Kaminaga, A. Nagatsu, T. Akiyama, N. Sugimoto, T. Yamazaki, and T. Maitani Production of unnatural glucosides of curcumin with drastically enchanced water solubility by cell suspension cultures of catharanthus roseus FEBS Lett. 555 2003 311 316 (Pubitemid 37486047)
28. M. Kanai, Y. Otsuka, K. Otsuka, M. Sato, T. Nishimura, Y. Mori, M. Kawaguchi, E. Hatano, Y. Kodama, S. Matsumoto, Y. Murakami, A. Imaizumi, T. Chiba, J. Nishihira, and H. Shibata A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (theracurmin) in cancer patients Cancer Chemother. Pharmacol. 71 2013 1521 1530
29. A. Karewicz, D. Bielska, A. Loboda, B. Gzyl-Malcher, J. Bednar, A. Jozkowicz, J. Dulak, and M. Nowakowska Curcumin-containing liposomes stabilized by thin layers of chitosan derivatives Colloids Surf. B Biointerfaces 109 2013 307 316
30. N.M. Khalil, T.C. do Nascimento, D.M. Casa, L.F. Dalmolin, A.C. de Mattos, I. Hoss, M.A. Romano, and R.M. Mainardes Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats Colloids Surf. B Biointerfaces 101 2013 353 360
31. T.M. Kolev, E.A. Velcheva, B.A. Stamboliyska, and M. Spiteller DTF and experimental studies of the structure and vibrational spectra of curcumin Int. J. Quantum Chem. 102 2005 1069 1079 (Pubitemid 40566988)
32. S.M. Konstantinov, H. Eibl, and M.R. Berger BCR-ABL influences the anti leukaemik efficacy of alkylphopsphocholines Br. J. Haematol. 107 1999 365 380
33. K. Krenek, M. Kuldova, K. Hulikova, I. Stibor, P. Lhotak, M. Dudic, J. Budka, H. Pelantova, K. Bezouska, A. Fiserova, and V. Kren N-acetyl-D- glucosamine substituted calix[4]arenes as stimulators of NK cell-mediated antitumor immune response Carbohydr. Res. 342 2007 1781 1792 (Pubitemid 47058060)
34. S. Kunsagi-Mate, K. Szabo, B. Lemli, I. Bitter, G. Nagy, and L. Kollar Host-guest interaction between water-soluble calix[6]arene hexasulfonate and p-nitrophenol Thermochim. Acta 425 2005 121 126 (Pubitemid 40082677)
35. C. Li, Y. Zhang, T. Su, L. Feng, Y. Long, and Z. Chen Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin Int. J. Nanomed. 7 2012 5995 6002
36. B. Liu, Z. Xiaoai, J. Zeng, and J. Zhao Preparation and physicochemical characterization of the supramolecular inclusion complex of naringin dihydrochalcone and hydroxypropyl-β-cyclodextrin Food Res. Int. 54 2013 691 696
37. T. Loftsson, D. Hreinsdottir, and M. Masson Evaluation of cyclodextrin solubilization of drugs Int. J. Pharm. 302 2005 18 28 (Pubitemid 41244817)
38. A. Lubbad, M.A. Oriowo, and I. Khan Curcumin attenuates inflammation through inhibition of TLR-4 receptor in experimental colitis Mol. Cell. Biochem. 322 2009 127 135
39. A.D. Martin, and C.L. Raston Multifunctional p-phosphonated calixarenes Chem. Commun. (Camb) 47 2011 9764 9772
40. D. Michel, J.M. Chitanda, R. Balogh, P. Yang, J. Singh, U. Das, A. El-Aneed, J. Dimmock, R. Verrall, and I. Badea Design and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanoma Eur. J. Pharm. Biopharm. 81 2012 548 556
41. D. Momekova, D. Budurova, E. Drakalska, S. Shenkov, G. Momekov, B. Trzebicka, N. Lambov, E. Tashev, and S. Rangelov Aggregation behavior and in vitro biocompatibility study of octopus-shaped macromolecules based on tert-butylcalix[4]arenes Int. J. Pharm. 436 2012 410 417
42. T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J. Immunol. Methods 65 1983 55 63 (Pubitemid 14203433)
43. M. Pandelidou, K. Dimas, A. Georgopoulos, S. Hatziantoniou, and C. Demetzos Preparation and characterization of lyophilised egg PC liposomes incorporating curcumin and evaluation of its activity against colorectal cancer cell lines J. Nanosci. Nanotechnol. 11 2011 1259 1266
44. M.B. Patel, N.N. Valand, N.R. Modi, K.V. Joshi, U. Harikrishnan, S.P. Kumar, Y.T. Jasrai, and S.K. Menon Effects on p-sulfonatocalix[4]resorcinarene (PSC[4]R) on the solubility and bioavailability of a poorly water soluble drug lamotrigine (LMN) and computional investigation RSC Adv. 3 2013 15971 15981
45. F. Perret, A.N. Lazar, and A.W. Coleman Biochemistry of the para-sulfonato-calix[n]arenes Chem. Commun. (Camb) 2006 2425 2438 (Pubitemid 43877069)
46. N. Pippa, F. Psarommati, Pispas St, and C. Demetzos The shape/morphology balance: a study of stealth liposomes via fractal analysis and drug encapsulation Pharm. Res. 30 2013 2385 2395
47. N. Pippa, E. Kaditi, S. Pispas, and C. Demetzos PEO-b-PCL-DPPC chimeric nanocarriers: self-assembly aspects in aqueous and biological media and drug incorporation Soft Matter 9 2013 4073 4082
48. N. Pippa, M. Merkouraki, Pispas St, and C. Demetzos DPPC:MPOx chimeric advanced drug delivery nano systems (chi-aDDnSs): physicochemical and structural characterization, stability and drug release studies Int. J. Pharm. 450 2013 1 10
49. K.I. Priyadarsini Photophysics, photochemistry and photobiology of curcumin: studies from organic solutions, bio-mimetics and living cells J. Photochem. Photobiol. C: Photochem. Rev. 10 2009 81 95
50. H. Rachmawati, C.A. Edityaningrum, and R. Mauludin Molecular inclusion complex of curcumin-beta-cyclodextrin nanoparticle to enhance curcumin skin permeability from hydrophilic matrix gel AAPS PharmSciTech 14 2013 1303 1312
51. S. Rahman, S. Cao, K.J. Steadman, M. Wei, and H.S. Parekh Native and beta-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer Drug Deliv. 19 2012 346 353
52. G. Rouser, S. Fleisner, and A. Yamamoto Two dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots Lipids 5 1970 494 496
53. P. Shahgaldian, M.A. Sciotti, and U. Pieles Amino-substituted amphiphilic calixarenes: self-assembly and interactions with DNA Langmuir 24 2008 8522 8526
54. R.A. Sharma, W.P. Steward, and A.J. Gescher Pharmacokinetics and pharmacodynamics of curcumin Adv. Exp. Med. Biol. 595 2007 453 470
55. A. Shehzad, F. Wahid, and Y.S. Lee Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials Arch. Pharm. (Weinheim) 343 2010 489 499
56. S. Singh, and A. Khar Biological effects of curcumin and its role in cancer chemoprevention and therapy Anticancer Agents Med. Chem. 6 2006 259 270 (Pubitemid 43796643)
57. Q. Tan, J. Wu, Y. Li, H. Mei, C. Zhao, and J. Zhang A supermolecular curcumin for enhanced antiproliferative and proapoptotic activities: molecular characteristics, computer modeling and in vivo pharmacokinetics Nanotechnology 24 2013 035102
58. D. Taton, M. Saule, J. Logan, R. Duran, S. Hou, E.L. Chaikof, and Y. Gnanou Polymerization of ethylene oxide with a calixarene-based precursor: synthesis of eight-arm poly(ethylene oxide) stars by the core-first methodology J. Polym. Sci. Part A: Polym. Chem. 41 2003 1669 1676 (Pubitemid 36602244)
59. E.V. Ukhatskaya, S.V. Kurkov, S.E. Matthews, A. Amani El Faguic, C. Amiel, F. Dalmas, and T. Loftsson Evaluation of a cationic calix[4]arene: Solubilization and self-aggregation ability Int. J. Pharm. 402 2010 10 19
60. S.J. Wallace, T.W. Kee, and D.M. Huang Molecular basis of binding and stability of curcumin in diamide-linked gamma-cyclodextrin dimers J. Phys. Chem. B 117 2013 12375 12382
61. V.R. Yadav, S. Suresh, K. Devi, and S. Yadav Effect of cyclodextrin complexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model AAPS PharmSciTech 10 2009 752 762
62. M.M. Yallapu, M. Jaggi, and S.C. Chauhan beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells Colloids Surf. B Biointerfaces 79 2010 113 125
63. M.M. Yallapu, M. Jaggi, and S.C. Chauhan Poly(beta-cyclodextrin)/curcumin self-assembly: a novel approach to improve curcumin delivery and its therapeutic efficacy in prostate cancer cells Macromol. Biosci. 10 2010 1141 1151
64. L. Zhongfa, M. Chiu, J. Wang, W. Chen, W. Yen, P. Fan Havard, L.D. Yee, and K.K. Chan Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice Cancer Chemother. Pharmacol. 69 2012 679 689
65. H. Zhou, C.S. Beevers, and S. Huang The targets of curcumin Curr. Drug Targets 12 2011 332 347